Skip to content

Clinical trials

Neurocognitive Disorders trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurocognitive Disorders Country / region: Poland Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20142
20172
20181
20202
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Completed3
Unknown status2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Alkahest, Inc.1
Eli Lilly and Company1
Genentech, Inc.1
Hoffmann-La Roche1
Inmune Bio, Inc.1
MapLight Therapeutics1
Medical University of Lublin1
Military Institute od Medicine National Research Institute1
Pomeranian Medical University Szczecin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurocognitive Disorders11
Brain Diseases8
Dementia8
Alzheimer Disease7
Central Nervous System Diseases7
Mental Disorders7
Nervous System Diseases7
Neurodegenerative Diseases7
Tauopathies6
Cognitive Dysfunction2

Trials

Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.